Applicant, as named in the Orange Book
Delcath Systems Inc
Next listed expiry: Hepzato on 17 Sep 2034. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Hepzato NDA 201848 melphalan hydrochloride | 17 Sep 2034 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.